Discovery and characterization of selective orexin receptor antagonists

被引:0
|
作者
Shireman, Brock T. [1 ]
Bonaventure, Pascal [1 ]
Letavic, Michael A. [1 ]
Lebold, Terry A. [1 ]
Dugovic, Christine [1 ]
Lord, Brian [1 ]
Morton, Kirsten L. [1 ]
Nepomuceno, Diane [1 ]
Shelton, Jonathan [1 ]
Aluisio, Leah [1 ]
Fraser, Ian [1 ]
Acton, Paul [2 ]
Johnson, Phil [3 ]
Shekhar, Anantha [4 ]
Lovenberg, Timothy W. [1 ]
Carruthers, Nicholas I. [1 ]
机构
[1] Janssen Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA
[2] Janssen Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
[3] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
333-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Orexin, orexin receptor antagonists and central cardiovascular control
    Carrive, Pascal
    FRONTIERS IN NEUROSCIENCE, 2013, 7
  • [22] The orexin story and orexin receptor antagonists for the treatment of insomnia
    Muehlan, Clemens
    Roch, Catherine
    Vaillant, Cedric
    Dingemanse, Jasper
    JOURNAL OF SLEEP RESEARCH, 2023, 32 (06)
  • [23] Discovery, evaluation, and characterization of nuclear receptor antagonists
    Turner, BA
    Grover, GS
    Lee, PH
    Parker, CN
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 449A - 449A
  • [24] Discovery of potent and selective isoxazoline antagonists of the vitronectin receptor
    Pitts, WJ
    Wityak, J
    Jetter, J
    Harlow, PP
    Corjay, MH
    Mousa, SA
    Wexler, RR
    Jadhav, PK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U886 - U886
  • [25] Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists
    Stasi, Luigi Piero
    Artusi, Roberto
    Bovino, Clara
    Buzzi, Benedetta
    Canciani, Luca
    Caselli, Gianfranco
    Colace, Fabrizio
    Garofalo, Paolo
    Giambuzzi, Silvia
    Larger, Patrice
    Letari, Ornella
    Mandelli, Stefano
    Perugini, Lorenzo
    Pucci, Sabrina
    Salvi, Matteo
    Toro, PierLuigi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (09) : 2653 - 2658
  • [26] GPCR structure-based drug discovery: Identification of dual orexin antagonists and orexin-1 selective antagonists for the treatment of insomnia and addiction disorders
    Christopher, John A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [27] Evaluation of Selective Orexin Receptor Antagonists in Preclinical Models of Panic Attack Provocation
    Bonaventure, Pascal
    Shekhar, Anantha
    Shireman, Brock
    Frederici, Lauren
    Molosh, Andrei
    Johnson, Philip
    BIOLOGICAL PSYCHIATRY, 2019, 85 (10) : S31 - S31
  • [28] From NMDA receptor antagonists to discovery of selective σ2 receptor ligands
    Gitto, Rosaria
    De Luca, Laura
    Ferro, Stefania
    Scala, Angela
    Ronsisvalle, Simone
    Parenti, Carmela
    Prezzavento, Orazio
    Buemi, Maria Rosa
    Chimirri, Alba
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (01) : 393 - 397
  • [29] Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists
    Morgan, BP
    Swick, AG
    Hargrove, DM
    LaFlamme, JA
    Moynihan, MS
    Carroll, RS
    Martin, KA
    Lee, E
    Decosta, D
    Bordner, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) : 2417 - 2424
  • [30] Discovery of JNJ-61393215: Selective orexin-1 receptor antagonist
    Lebold, Terry
    Gelin, Christine
    Preville, Cathy
    Ziff, Jeannie
    Coate, Heather
    Dvorak, Curt
    Bonaventure, Pascal
    Koudriakova, Tatiana
    Lord, Brian
    Nepomuceno, Diane
    Rizzolio, Michele
    Coe, Kevin
    Ndifor, Anthony
    Dugovic, Christine
    Shelton, Jonathan
    Pippel, Daniel
    Lovenberg, Timothy
    Carruthers, Nicholas
    Shireman, Brock
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258